Ssinabulya Isaac, Kayima James, Longenecker Chris, Luwedde Mary, Semitala Fred, Kambugu Andrew, Ameda Faith, Bugeza Sam, McComsey Grace, Freers Juergen, Nakanjako Damalie
Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
PLoS One. 2014 Feb 28;9(2):e89537. doi: 10.1371/journal.pone.0089537. eCollection 2014.
The increased immune activation and inflammation of chronic HIV-infection and the characteristic dyslipidemias associated with HIV infection and antiretroviral therapy (ART) contribute to an increased risk of atherosclerotic vascular disease among HIV-infected adults. There is an emerging need to understand determinants of cardiovascular disease (CVD) among individuals aging with HIV in sub-Saharan Africa. We determined the prevalence of subclinical atherosclerosis [carotid intima media thickness (CIMT) ≥ 0.78 mm] and its correlation with traditional CVD risk factors among HIV-infected adults.
In a cross-sectional study, HIV-infected adults (ART-naïve and ART-treated) were consecutively selected from patients' enrollment registers at two large HIV clinics at Mulago Hospital, Kampala, Uganda. We measured traditional CVD risk factors including age, biophysical profile, fasting blood sugar and serum lipid profile as well as biomarkers of inflammation. High resolution ultrasound was used to measure common carotid CIMT.
Of 245 patients, Median age [Interquartile range (IQR)] 37 years (31-43), 168 (69%) were females; and 100 (41%) were ART-treated for at least 7 years. Overall, 34/186 (18%) had subclinical atherosclerosis; of whom 15/108 (14%) were ART-naïve whereas 19/78 (24%) were ART-treated. Independent predictors of subclinical atherosclerosis included age [odds ratio (OR) 1.83 per 5-year increase in age; 95% confidence interval (CI) 1.24-2.69; p = 0.002], body mass index (BMI); OR 1.15; CI 1.01-1.31; p = 0.041 and high low density lipoprotein (LDL) [OR 2.99; CI 1.02-8.78, p = 0.046]. High sensitivity C-reactive protein (hsCRP) was positively correlated with traditional cardio-metabolic risk factors including waist circumference (r = 0.127, p = 0.05), triglycerides (r = 0.19, p = 0.003) and Total Cholesterol: High Density Lipoprotein ratio (TC:LDL) (r = 0.225, p<0.001).
The prevalence of subclinical atherosclerosis was 18% among HIV-infected adults in Uganda. Traditional CVD risk factors were associated with subclinical atherosclerosis. We recommend routine assessment of traditional CVD risk factors within HIV care and treatment programs in sub-Saharan Africa.
慢性HIV感染导致的免疫激活和炎症增加,以及与HIV感染和抗逆转录病毒疗法(ART)相关的特征性血脂异常,使HIV感染的成年人患动脉粥样硬化性血管疾病的风险增加。在撒哈拉以南非洲,越来越需要了解随着年龄增长感染HIV的个体患心血管疾病(CVD)的决定因素。我们确定了HIV感染成年人中亚临床动脉粥样硬化[颈动脉内膜中层厚度(CIMT)≥0.78mm]的患病率及其与传统CVD危险因素的相关性。
在一项横断面研究中,从乌干达坎帕拉穆拉戈医院的两家大型HIV诊所的患者登记册中连续选取HIV感染的成年人(未接受ART治疗和接受ART治疗的)。我们测量了传统的CVD危险因素,包括年龄、生物物理特征、空腹血糖和血脂谱以及炎症生物标志物。使用高分辨率超声测量颈总动脉CIMT。
在245名患者中,中位年龄[四分位间距(IQR)]为37岁(31 - 43岁),168名(69%)为女性;100名(41%)接受ART治疗至少7年。总体而言,186名中有34名(18%)患有亚临床动脉粥样硬化;其中108名未接受ART治疗的患者中有15名(14%),而接受ART治疗的78名患者中有19名(24%)。亚临床动脉粥样硬化的独立预测因素包括年龄[年龄每增加5岁,比值比(OR)为1.83;95%置信区间(CI)为1.24 - 2.69;p = 0.002]、体重指数(BMI);OR为1.15;CI为1.01 - 1.31;p = 0.041以及高低密度脂蛋白(LDL)[OR为2.99;CI为1.02 - 8.78,p = 0.046]。高敏C反应蛋白(hsCRP)与传统的心脏代谢危险因素呈正相关,包括腰围(r = 0.127,p = 0.05)、甘油三酯(r = 0.19,p = 0.003)和总胆固醇:高密度脂蛋白比值(TC:LDL)(r = 0.225,p<0.001)。
乌干达HIV感染成年人中亚临床动脉粥样硬化的患病率为18%。传统的CVD危险因素与亚临床动脉粥样硬化相关。我们建议在撒哈拉以南非洲的HIV护理和治疗项目中对传统的CVD危险因素进行常规评估。